Selected carboxyl-group bioisosteres of mycophenolic acid with divergent biological profiles
BACKGROUND: Mycophenolic acid (MPA) is an immunosuppressive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). Bioisosteric replacement of its carboxyl group may modulate potency, cellular selectivity, and the overall biological profile. This study compared cyclic 1,2,4-oxadiazole derivatives and non-cyclic carboxylate bioisosteres to assess their effects on histone deacetylase 6 (HDAC6), IMPDH-related activity, redox properties, and cellular responses. METHODS: The compounds were synthesised by dehydrative cyclisation of MPA with amidoximes or by coupling reactions affording hydroxamic acid, hydrazide, and amide analogues. They were evaluated by molecular docking to IMPDH type 2 (IMPDH2) and HDAC6, HDAC6 enzymatic inhibition, metabolic cytotoxicity and flow-cytometric proliferation assays in peripheral blood mononuclear cells (PBMCs) and T-Jurkat cells, guanosine monophosphate (GMP) rescue, and 2,2-diphenyl-1-picrylhydrazyl radical scavenging. RESULTS: Docking showed scaffold-dependent binding patterns. Non-cyclic bioisosteres showed more MPA-like predicted IMPDH2 binding modes and, when bearing zinc-binding groups, were more compatible with the zinc-containing HDAC6 catalytic region, whereas oxadiazoles adopted alternative predicted binding modes. In the HDAC6 enzymatic assay, pyridyl oxadiazoles were the most active cyclic derivatives, while the hydroxamic acid derivative showed nanomolar inhibition. In T-Jurkat cells, the newly synthesised derivatives showed substantially lower cytotoxic potency than MPA and mycophenolate mofetil (MMF), while several retained measurable antiproliferative activity. GMP rescue suggested functional divergence: non-cyclic bioisosteres showed GMP-rescuable antiproliferative effects consistent with guanine nucleotide depletion, whereas selected oxadiazoles were not rescued under these conditions. The antioxidant assay highlighted hydroxamic and hydrazide derivatives and the 2-furanyl oxadiazole. CONCLUSIONS: Carboxyl-group bioisosterism of MPA reshaped enzyme inhibition, redox activity, and cellular profiles. Non-cyclic derivatives retained GMP-rescuable antiproliferative profiles, with the hydroxamic acid analogue exhibiting particularly strong HDAC6 inhibition, whereas 1,2,4-oxadiazoles generally showed reduced cytotoxic potency and distinct cellular response patterns.
Authors
- Damian Garbicz (ORCID: https://orcid.org/0000-0001-5417-8531)
- Dominique Schols (ORCID: https://orcid.org/0000-0003-3256-5850)
- Mario Smet (ORCID: https://orcid.org/0000-0002-3250-740X)
- Steven De Jonghe (ORCID: https://orcid.org/0000-0002-3872-6558)
- Agnieszka Viapiana (ORCID: https://orcid.org/0000-0002-4398-1780)
- G. Cholewiński (ORCID: https://orcid.org/0000-0002-1664-8421)
- Juliusz Maksymilian Walczak (ORCID: https://orcid.org/0000-0003-4226-6731)
- Dorota Iwaszkiewicz‐Grześ (ORCID: https://orcid.org/0000-0003-1177-1874)
- Leentje Persoons (ORCID: https://orcid.org/0000-0002-7898-0868)
- Alina Plenis (ORCID: https://orcid.org/0000-0002-0507-2770)
- Saba Shahrivari-Baviloliaei (ORCID: https://orcid.org/0000-0002-2721-5592)
- Alan Bielecki (ORCID: https://orcid.org/0009-0001-4758-0546)
Institutions
- Université Libre de Bruxelles (BE)
- Gdańsk University of Technology (PL)
- Rega Institute for Medical Research (BE)
- National Institute of Oncology (HU)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Gdańsk Medical University (PL)
- KU Leuven (BE)
Publication Details
- Journal
- Pharmacological Reports
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s43440-026-00931-w
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds Wetenschappelijk Onderzoek
- Politechnika Gdańska
- Narodowa Agencja Wymiany Akademickiej